New Zealand markets closed

Acticor Biotech SAS (ALACT.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
0.4690+0.1490 (+46.56%)
At close: 05:35PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
11,021
11,021
10,761
8,398
5,481
Selling general and administrative
2,731
2,731
3,569
3,526
1,600
Total operating expenses
17,551
17,551
15,102
11,831
7,562
Operating income or loss
-17,551
-17,551
-15,102
-11,831
-7,562
Interest expense
1,809
1,809
595
721
0
Income before tax
-18,640
-18,640
-15,878
-12,608
-7,651
Income tax expense
0
0
0
0
0
Income from continuing operations
-18,640
-18,640
-15,878
-12,608
-7,651
Net income
-18,640
-18,640
-15,878
-12,608
-7,651
Net income available to common shareholders
-18,640
-18,640
-15,878
-12,608
-7,651
Basic EPS
-1.67
-1.54
-1.51
-1.62
-0.73
Diluted EPS
-1.67
-1.54
-1.51
-1.62
-0.73
Basic average shares
11,089
12,068
10,546
7,780
10,546
Diluted average shares
11,089
12,068
10,546
7,780
10,546